Showing results (151-160 of 269) with videos related to
Sort By:
Pageof 27
Helicobacter|May 26, 2004
Pharmacoeconomics of gastrointestinal drug utilisation prior and post Helicobacter pylori eradicationRogier M Klok, Willem Jan van der Veen, Ger Th van der Werf, et al.Journal of Thrombosis and Haemostasis : JTH|August 12, 2005
High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic strokeF W G Leebeek, M P J Goor, A H C Guimaraes, et al.Arthritis Research & Therapy|December 17, 2008
Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control studyHarald E Vonkeman, Louise M A Braakman-Jansen, Rogier M Klok, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 25, 2005
Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendationsA F Y Al Hadithy, N K H de Boer, L J J Derijks, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 6, 2025
Sex hormone-binding globulin as a biomarker for metabolic risk in European women with polycystic ovary syndromeBo E van Bree, Denise M B van der Heijden, Ron J T van Golde, et al.Journal of Clinical Pharmacy and Therapeutics|January 24, 2008
Treatment of pregnant and non-pregnant rheumatic patients: a survey among Dutch rheumatologistsF Vroom, M A J F van de Laar, E N van Roon, et al.European Journal of Endocrinology|September 13, 2008
Plasma pigment epithelium-derived factor is positively associated with obesity in Caucasian subjects, in particular with the visceral fat depotPing Wang, Egbert Smit, Martijn C G J Brouwers, et al.Henry Ford Hospital Medical Journal|January 1, 1992
Long-term follow-up in four large MEN 2 families in The NetherlandsC J Lips, M J Berends, J Brouwers-Smalbraak, et al.Drug Safety|September 15, 2006
Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the futureFokaline Vroom, Hermien E K de Walle, Mart A J F van de Laar, et al.Diabetes, Obesity & Metabolism|November 25, 2017
Risk of a first-ever acute myocardial infarction and all-cause mortality with sulphonylurea treatment: A population-based cohort studyJudith van Dalem, Martijn C G J Brouwers, Coen D A Stehouwer, et al.Pageof 27